Türkay Toklu - Concepedia

Author

Türkay Toklu

Yeditepe University ORCID

Also Known As

Nalan Alan Selcuk, Nalan Alan Selçuk, T Toklu, T. Toklu, Toklu, T., Turkay Toklu, Türkay Toklu

Publications

727

Citations

H-Index

Concepts

All Affiliations

Yeditepe University Istanbul University Istanbul University-Cerrahpaşa Ankara University University of Missouri

About

Türkay Toklu is an author at Yeditepe University specializing in medicine, radiology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	364
2	Health Sciences	3	3	77
3	Nursing	1	1	24
4	Emergency Medicine	1	1	20
5	Neurology	1	1	24

Türkay Toklu

Publications

668

Citations

H-Index

Page 1

	Year	Citations
Pre-therapeutic dosimetry of normal organs and tissues of 177Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer Levent Kabasakal, Mohammad Abuqbeitah, Aslan Aygün, European Journal of Nuclear Medicine and Molecular Imaging Normal OrgansUrologyOncologyGenitourinary CancerMedicine	2015	206
Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry Levent Kabasakal, Türkay Toklu, Nami Yeyin, Molecular Imaging and Radionuclide Therapy	2017	79
Patient doses and dosimetric evaluations in interventional cardiology Doğan Bor, Turan Olğar, Türkay Toklu, Physica Medica Percutaneous Coronary InterventionCardiovascular DiseaseCoronary UnitPatient SafetyAcute Myocardial Infarction	2008	61
177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours Emre Demirci, Levent Kabasakal, Türkay Toklu, Nuclear Medicine Communications	2018	61
Assessment of radiation doses to cardiologists during interventional examinations D. Bor, Turan Olğar, E Onal, Medical Physics	2009	31
Clinical Experience with [<sup>225</sup>Ac]Ac-PSMA Treatment in Patients with [<sup>177</sup>Lu]Lu-PSMA–Refractory Metastatic Castration-Resistant Prostate Cancer Nalan Alan Selçuk, Gamze Beydağı, Emre Demirci, Journal of Nuclear Medicine	2023	31
Post-therapy imaging of 225Ac-DOTATATE treatment in a patient with recurrent neuroendocrine tumor Meltem Ocak, Türkay Toklu, Emre Demirci, European Journal of Nuclear Medicine and Molecular Imaging Oncologic ImagingRecurrent Neuroendocrine TumorMedicineNeuroendocrine DisorderPost-therapy Imaging	2020	30
Effects of radiologists' skill and experience on patient doses in interventional examinations D. Bor, Tanzer Sancak, Türkay Toklu, Radiation Protection Dosimetry DiagnosisRadiologic EducationInterventional RadiologySurgeryPatient Doses	2008	24
Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance Kaan Akçay, Ali Kibar, Onur Erdem Şahin, European Journal of Nuclear Medicine and Molecular Imaging Significant Prostate CancerUrologyHealth SciencesMedical ImagingCancer Detection	2023	23
Initial Findings on the Use of [<sup>225</sup>Ac]Ac-DOTATATE Therapy as a Theranostic Application in Patients with Neuroendocrine Tumors Emre Demirci, Nalan Alan Selçuk, Gamze Beydağı, Molecular Imaging and Radionuclide Therapy	2023	21

Page 1